Has Isaiah Pittman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,532,063 in general payments to Isaiah Pittman, MD across 3,020 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Isaiah Pittman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Isaiah Pittman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Isaiah Pittman, MD

Endocrinology, Diabetes & Metabolism · Terre Haute, INNPI 1588638928

Payments from drug & device makers

$1,532,063in general payments, 2019–2025

Across 3,020 payments — averaging $507.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$530K
Novo Nordisk$350K
AstraZeneca$275K
Insulet Corporation$144K
Corcept Therapeutics$84K
Boehringer Ingelheim$62K
plus $86K from 42 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	893	$529,862
Novo Nordisk	545	$350,288
AstraZeneca(2 entities)	309	$275,307
Insulet Corporation	306	$143,980
Corcept Therapeutics	143	$84,167
Boehringer Ingelheim	109	$62,275
Merck	85	$43,282
Bayer	62	$26,423
Eli Lilly	9	$5,899
Amgen(2 entities)	98	$1,560
Cequr Corporation	4	$882
Medtronic(2 entities)	25	$803
Abbott	41	$794
Dexcom, Inc.	50	$777
Amarin Pharma, Inc.	50	$677
Mannkind Corporation	22	$653
Novartis	35	$627
Xeris Pharmaceuticals, Inc.	33	$607
Esperion Therapeutics, Inc.	41	$566
AbbVie	24	$401
Antares Pharma, Inc.	36	$375
Sanofi-aventis U.S. LLC	21	$348
Amneal Pharmaceuticals LLC	12	$246
Tandem Diabetes Care, Inc.	4	$155
Radius Health, Inc.	9	$141
Recordati_rare_diseases_inc.	8	$129
Gilead	1	$108
Lifescan, Inc.	8	$106
BETA Bionics, Inc.	4	$75
Amryt Pharma Holdings Ltd	4	$62
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$57
Regeneron Healthcare Solutions, Inc.	3	$47
Shire North American Group Inc	3	$43
Ultragenyx Pharmaceutical Inc.	2	$41
Echosens North America, Inc.	1	$36
EUSA Pharma (US) LLC	2	$35
IBSA Pharma Inc.	2	$27
Soleno Therapeutics, Inc.	1	$26
Currax Pharmaceuticals LLC	2	$25
Senseonics, Incorporated	1	$23
Ascendis Pharma Endocrinology Inc	1	$19
Kowa Pharmaceuticals America, Inc.	1	$17
Neurocrine Biosciences, Inc.	1	$17
Avvisto Therapeutics, LLC	1	$16
Companion Medical, Inc.	1	$16
Sequel Med Tech, LLC	1	$14
GRT US Holding, Inc.	1	$14
Zealand Pharma US, Inc.	1	$12

How this compares

$1,532,063 in reported general payments places this provider in the 95th percentile of 134 endocrinology, diabetes & metabolism providers in Indiana.

See all endocrinology, diabetes & metabolism providers in Indiana →

Medicare billing

Part B allowed, 2024

$225,015

Medicare patients

440

Services billed

2,516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Terre Haute

Edward RicoTerre Haute$135K
Mohammad AlamTerre Haute$28K
Carmella Evans-MolinaIndianapolis$6.3M
Ernest AsamoahIndianapolis$959K
Sana MeahMunster$829K
James MaloneIndianapolis$822K
Erica KretchmanRichmond$636K
Emily VeenemanSeymour$583K
Cary MariashIndianapolis$435K
Marian KirkmanIndianapolis$371K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →